Takotsubo cardiomyopathy, also known as stress-induced cardiomyopathy or "broken heart syndrome," is a reversible cardiac disorder characterized by left ventricular dysfunction without significant obstructive coronary artery disease. It is classically secondary to emotional stress in postmenopausal women but can also be secondary to physical stress. This report presents a unique case of takotsubo cardiomyopathy induced by intracranial hemorrhage in an 80-year-old female who presented with syncope.

Eagle syndrome is a condition that can present with a wide range of clinical manifestations, including orofacial pain, altered sensation, dysphagia, tinnitus, and ear pain, and is caused by the abnormal elongation of the styloid process or the mineralization of the stylohyoid ligament. We present a case of an incidental finding of Eagle syndrome in a 48-year-old African American patient with losartan-induced angioedema. The patient complained of a foreign body sensation in his throat and mild dysphagia, and a computed tomography scan of his neck showed ossification of bilateral stylohyoid ligaments. This case report highlights the importance of being on the lookout for other pathologies when ordering imaging for primary diagnoses.

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers are both classes of drugs used in the management of hypertension, heart failure, chronic kidney disease, and proteinuria. While angioedema induced by ACE inhibitors has been well-documented, angioedema induced by angiotensin receptor blockers (ARBs) has not. We present the case of losartan-induced angioedema requiring tracheostomy in a 48-year-old African American male. To our knowledge, there have only been twenty case reports published to date about losartan-induced angioedema. Although in the immediate short-term, our patient made a complete recovery, he had a sudden cardiac arrest a few months after the incident of angioedema and died.

Torsades de pointes occurs in the presence of a prolonged QTc interval, which has many congenital and acquired causes. Levetiracetam is a widely used anti-epileptic medication secondary to its favorable safety profile. We present a rare case of a 59-year-old male who developed torsades de pointes and cardiac arrest after levetiracetam administration. To our knowledge, there is only one other case report documenting torsades de pointes after levetiracetam administration, and our case report will be the first documenting cardiac arrest after levetiracetam administration.